中国成人重症患者血小板减少诊疗专家共识

2019-01-02 全军重症医学专业委员会 解放军医学杂志.2020,45(2):95-112.

血小板是直接参与血块形成和炎症调节的血细胞,血小板减少是重症患者常见的并发症。据统计,入住重症监护病房(intensive care unit,ICU)时成人重症患者的血小板减少发生率可达8.3%~67.6%,在ICU治疗期间血小板减少的发生率可达14%~44%。发生血小板减少的重症患者的出血事件和输血量也显著增加,甚至死亡风险也明显提升。因此,全军重症医学专业委员会重症凝血学组联合中华医学会检验

中文标题:

中国成人重症患者血小板减少诊疗专家共识

发布日期:

2019-01-02

简要介绍:

血小板是直接参与血块形成和炎症调节的血细胞,血小板减少是重症患者常见的并发症。据统计,入住重症监护病房(intensive care unit,ICU)时成人重症患者的血小板减少发生率可达8.3%~67.6%,在ICU治疗期间血小板减少的发生率可达14%~44%。发生血小板减少的重症患者的出血事件和输血量也显著增加,甚至死亡风险也明显提升。因此,全军重症医学专业委员会重症凝血学组联合中华医学会检验医学分会共同制定本共识,以便为临床工作提供相应指导。 2019年8月,由全军重症医学专业委员会联合中华医学会检验医学分会抽取专家组成共识编写委员会,经讨论确定共识包括血小板减少的定义、病因与病理生理学、诊断与鉴别诊断、治疗与预防五个部分,具体形成27条基本条目。依据重症医学、检验医学和输血医学的最新进展,分别对共识条目的相关内容进行审阅。并于2019年11月召开会议集中讨论,记录每位发言者对共识的意见和建议。根据会议所有专家要求进行修改,并经历数轮电话会议讨论,最终形成推荐意见。

 

拓展指南:血小板相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=中国成人重症患者血小板减少诊疗专家共识)] GetToolGuiderByIdResponse(projectId=1, id=b37a51c0018ae954, title=中国成人重症患者血小板减少诊疗专家共识, enTitle=, guiderFrom=解放军医学杂志.2020,45(2):95-112., authorId=null, author=, summary=血小板是直接参与血块形成和炎症调节的血细胞,血小板减少是重症患者常见的并发症。据统计,入住重症监护病房(intensive care unit,ICU)时成人重症患者的血小板减少发生率可达8.3%~67.6%,在ICU治疗期间血小板减少的发生率可达14%~44%。发生血小板减少的重症患者的出血事件和输血量也显著增加,甚至死亡风险也明显提升。因此,全军重症医学专业委员会重症凝血学组联合中华医学会检验, cover=, journalId=null, articlesId=null, associationId=1154, associationName=全军重症医学专业委员会, associationIntro=null, copyright=0, guiderPublishedTime=Wed Jan 02 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>血小板是直接参与血块形成和炎症调节的血细胞,血小板减少是重症患者常见的并发症。据统计,入住重症监护病房(intensive care unit,ICU)时成人重症患者的血小板减少发生率可达8.3%~67.6%,在ICU治疗期间血小板减少的发生率可达14%~44%。发生血小板减少的重症患者的出血事件和输血量也显著增加,甚至死亡风险也明显提升。因此,全军重症医学专业委员会重症凝血学组联合中华医学会检验医学分会共同制定本共识,以便为临床工作提供相应指导。 2019年8月,由全军重症医学专业委员会联合中华医学会检验医学分会抽取专家组成共识编写委员会,经讨论确定共识包括血小板减少的定义、病因与病理生理学、诊断与鉴别诊断、治疗与预防五个部分,具体形成27条基本条目。依据重症医学、检验医学和输血医学的最新进展,分别对共识条目的相关内容进行审阅。并于2019年11月召开会议集中讨论,记录每位发言者对共识的意见和建议。根据会议所有专家要求进行修改,并经历数轮电话会议讨论,最终形成推荐意见。</P> <P> </P>拓展指南:<strong>与<font color=red>血小板</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=687521c00183e332" title="2019 ASH指南:免疫性血小板减少症" target=_blank>2019 ASH指南:免疫性血小板减少症</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=954861c00180eae0" title="发热伴血小板减少综合征中西医结合诊疗专家共识" target=_blank>发热伴血小板减少综合征中西医结合诊疗专家共识</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=b4e2c1c001e73963" title="急性冠状动脉综合征非血运重建患者抗血小板治疗中国专家共识(2018)" target=_blank>急性冠状动脉综合征非血运重建患者抗血小板治疗中国专家共识(2018)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=f130e1c001e1a7ff" title="2019 ACOG实践简报:妊娠期血小板减少症(No.207)" target=_blank>2019 ACOG实践简报:妊娠期血小板减少症(No.207)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=d4b9f1c00169582a" title="2019 BSH最佳实践指南:接受类固醇治疗的免疫血小板减少症患者糖皮质激素性骨质疏松症的预防" target=_blank>2019 BSH最佳实践指南:接受类固醇治疗的免疫血小板减少症患者糖皮质激素性骨质疏松症的预防</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E8%A1%80%E5%B0%8F%E6%9D%BF" target=_blank>有关血小板更多指南</a></ul>, tagList=[TagDto(tagId=98500, tagName=成人重症患者), TagDto(tagId=996, tagName=血小板减少)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=38, categoryName=急重症科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=12772, appHits=827, showAppHits=5, pcHits=3652, showPcHits=9478, likes=48, shares=48, comments=23, approvalStatus=1, publishedTime=Sun Jan 05 23:54:39 CST 2020, publishedTimeString=2019-01-02, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Jan 05 23:54:39 CST 2020, updatedBy=null, updatedName=null, updatedTime=Thu Jan 04 01:31:17 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=中国成人重症患者血小板减少诊疗专家共识)])
中国成人重症患者血小板减少诊疗专家共识
下载请点击:
评论区 (17)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1193449, encodeId=4357119344978, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211018/cf8f772ab38148e8ac2cb234229f8f71/4fea1ac6fb8a4a6ca1be5e0817ee1b81.jpg, createdBy=65685639002, createdName=我不是针对谁, createdTime=Tue Feb 15 01:24:54 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009921, encodeId=15e3100992106, content=<a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb05290382, createdName=14860c3dm72暂无昵称, createdTime=Sat Aug 21 08:33:12 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009920, encodeId=cc80100992003, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb05290382, createdName=14860c3dm72暂无昵称, createdTime=Sat Aug 21 08:33:05 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009919, encodeId=3cb31009919be, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb05290382, createdName=14860c3dm72暂无昵称, createdTime=Sat Aug 21 08:32:57 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003870, encodeId=281a10038e00c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a71f5555722, createdName=ms1000001448679741, createdTime=Fri Jul 30 14:49:05 CST 2021, time=2021-07-30, status=1, ipAttribution=)]
    2022-02-15 我不是针对谁

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1193449, encodeId=4357119344978, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211018/cf8f772ab38148e8ac2cb234229f8f71/4fea1ac6fb8a4a6ca1be5e0817ee1b81.jpg, createdBy=65685639002, createdName=我不是针对谁, createdTime=Tue Feb 15 01:24:54 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009921, encodeId=15e3100992106, content=<a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb05290382, createdName=14860c3dm72暂无昵称, createdTime=Sat Aug 21 08:33:12 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009920, encodeId=cc80100992003, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb05290382, createdName=14860c3dm72暂无昵称, createdTime=Sat Aug 21 08:33:05 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009919, encodeId=3cb31009919be, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb05290382, createdName=14860c3dm72暂无昵称, createdTime=Sat Aug 21 08:32:57 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003870, encodeId=281a10038e00c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a71f5555722, createdName=ms1000001448679741, createdTime=Fri Jul 30 14:49:05 CST 2021, time=2021-07-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1193449, encodeId=4357119344978, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211018/cf8f772ab38148e8ac2cb234229f8f71/4fea1ac6fb8a4a6ca1be5e0817ee1b81.jpg, createdBy=65685639002, createdName=我不是针对谁, createdTime=Tue Feb 15 01:24:54 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009921, encodeId=15e3100992106, content=<a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb05290382, createdName=14860c3dm72暂无昵称, createdTime=Sat Aug 21 08:33:12 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009920, encodeId=cc80100992003, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb05290382, createdName=14860c3dm72暂无昵称, createdTime=Sat Aug 21 08:33:05 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009919, encodeId=3cb31009919be, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb05290382, createdName=14860c3dm72暂无昵称, createdTime=Sat Aug 21 08:32:57 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003870, encodeId=281a10038e00c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a71f5555722, createdName=ms1000001448679741, createdTime=Fri Jul 30 14:49:05 CST 2021, time=2021-07-30, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1193449, encodeId=4357119344978, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211018/cf8f772ab38148e8ac2cb234229f8f71/4fea1ac6fb8a4a6ca1be5e0817ee1b81.jpg, createdBy=65685639002, createdName=我不是针对谁, createdTime=Tue Feb 15 01:24:54 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009921, encodeId=15e3100992106, content=<a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb05290382, createdName=14860c3dm72暂无昵称, createdTime=Sat Aug 21 08:33:12 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009920, encodeId=cc80100992003, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb05290382, createdName=14860c3dm72暂无昵称, createdTime=Sat Aug 21 08:33:05 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009919, encodeId=3cb31009919be, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb05290382, createdName=14860c3dm72暂无昵称, createdTime=Sat Aug 21 08:32:57 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003870, encodeId=281a10038e00c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a71f5555722, createdName=ms1000001448679741, createdTime=Fri Jul 30 14:49:05 CST 2021, time=2021-07-30, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1193449, encodeId=4357119344978, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211018/cf8f772ab38148e8ac2cb234229f8f71/4fea1ac6fb8a4a6ca1be5e0817ee1b81.jpg, createdBy=65685639002, createdName=我不是针对谁, createdTime=Tue Feb 15 01:24:54 CST 2022, time=2022-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009921, encodeId=15e3100992106, content=<a href='/topic/show?id=d55f104233bd' target=_blank style='color:#2F92EE;'>#梅斯医学科研互助群#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104233, encryptionId=d55f104233bd, topicName=梅斯医学科研互助群)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb05290382, createdName=14860c3dm72暂无昵称, createdTime=Sat Aug 21 08:33:12 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009920, encodeId=cc80100992003, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb05290382, createdName=14860c3dm72暂无昵称, createdTime=Sat Aug 21 08:33:05 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009919, encodeId=3cb31009919be, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb05290382, createdName=14860c3dm72暂无昵称, createdTime=Sat Aug 21 08:32:57 CST 2021, time=2021-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003870, encodeId=281a10038e00c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a71f5555722, createdName=ms1000001448679741, createdTime=Fri Jul 30 14:49:05 CST 2021, time=2021-07-30, status=1, ipAttribution=)]
    2021-07-30 ms1000001448679741

    学习

    0